Physician profile
Cali Clark
NPI 1538734058
$1,516.37
in general payments reported to CMS, 2019-2025
12 companies · $1,097 in 2025
The $1,097 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $419 · 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.52 |
| Education | $136.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $389.51 | 2024-2025 | Impella |
| Abbott Laboratories | $294.35 | 2024-2025 | Ensite, Ultreon, Thoratec Heartmate 3 Lvas Implant Kit |
| Asahi Intecc USA, INC. | $172.00 | 2025 | Asahi Coronary Wires |
| Teleflex LLC | $144.13 | 2025 | Turnpike |
| Regeneron Pharmaceuticals, INC. | $126.40 | 2025 | Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $123.24 | 2024-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.28 | 2025 | Jardiance |
| Heartflow, INC. | $79.66 | 2025 | |
| Axsome Therapeutics, INC. | $35.00 | 2025 | Auvelity |
| Impulse Dynamics (USA) INC. | $31.92 | 2024 | Optimizer |
| Angiodynamics, INC. | $17.39 | 2025 | Alphavac |
| Bayer Healthcare Pharmaceuticals INC. | $13.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cali Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.